Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer

Summary

The purpose of the study is to modify a type of counseling called "Individual Meaning Centered Psychotherapy" to meet the needs of Chinese cancer patients. Many cancer patients use counseling or other resources to help cope with the emotional burden of their illnesses. Counseling often helps them cope with cancer by giving them a place to express their feelings. "Meaning-Centered" counseling aims to teach cancer patients how to maintain or even increase a sense of meaning and purpose in their lives, despite cancer.

Conditions

• Advanced Cancer

Interventions

BEHAVIORAL

In-depth Patient Interviews

BEHAVIORAL

Adaptation of IMCP for Chinese Immigrant Cancer Patients

BEHAVIORAL

Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3 and Phase 4)

The six sessions will be delivered every or every other week over a span of 6-16 weeks, depending on participant and interventionist availability. Sessions may also be delivered within 2 weeks to accommodate schedules. Sessions will take place via MSK-approved videoconferencing platforms (e.g. Zoom) or by telephone, depending on participant preference. The IMCP-Ch intervention will be delivered via telehealth in Mandarin Chinese by a bilingual interventionist or in English (for bilingual Chinese and English-speaking patients who prefer English) by an English-speaking therapist or through English-to-Mandarin Remote Simultaneous Medical Interpretation (RSMI), depending on participants' preference. All Phase 4 sessions will be digitally audio-recorded and saved to Zoom cloud. Cloud recording will be deleted from Zoom after the files have been uploaded.

Sponsors & Collaborators

• Queens Cancer Center of Queens Hospital

  collaborator OTHER

• Charles B. Wang Community Health Center (CBWCHC)

  collaborator UNKNOWN

• American Cancer Society - Asian Initiatives

  collaborator OTHER

• New York Coalition for Asian American Mental Health (NYCAAMH)

  collaborator UNKNOWN

• New York Hospital Queens

  collaborator OTHER

• Chinese Christian Herald Crusades (CCHC)

  collaborator OTHER

• Cheung and Kan Medical Group, PLLC

  collaborator UNKNOWN

• The City College of New York

  collaborator OTHER

• MediSys Health Network

  collaborator OTHER

• Memorial Sloan Kettering Cancer Center

  lead OTHER

Principal Investigators

• Florence Lui, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age

21 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-04-30

Primary Completion

2027-02-15

Completion

2027-02-15

Countries

• United States

Study Locations